A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

NCT03733353 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Atopic Dermatitis

Interventions

DRUG: EDP1815
DRUG: Placebo oral capsule
DRUG: Placebo oral tablet

Sponsor

Evelo Biosciences, Inc.